105 related articles for article (PubMed ID: 11675936)
41. Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.
Morales MC; Pérez-Yarza G; Nieto-Rementeria N; Boyano MD; Jangi M; Atencia R; Asumendi A
Anticancer Res; 2005; 25(3B):1945-51. PubMed ID: 16158929
[TBL] [Abstract][Full Text] [Related]
42. MMPT as a reactive oxygen species generator induces apoptosis via the depletion of intracellular GSH contents in A549 cells.
Zhao YF; Zhang C; Suo YR
Eur J Pharmacol; 2012 Aug; 688(1-3):6-13. PubMed ID: 22609960
[TBL] [Abstract][Full Text] [Related]
43. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
[TBL] [Abstract][Full Text] [Related]
44. Auranofin induces apoptosis and necrosis in HeLa cells via oxidative stress and glutathione depletion.
You BR; Shin HR; Han BR; Kim SH; Park WH
Mol Med Rep; 2015 Feb; 11(2):1428-34. PubMed ID: 25370167
[TBL] [Abstract][Full Text] [Related]
45. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
[TBL] [Abstract][Full Text] [Related]
46. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
Liebmann JE; Hahn SM; Cook JA; Lipschultz C; Mitchell JB; Kaufman DC
Cancer Res; 1993 May; 53(9):2066-70. PubMed ID: 8097674
[TBL] [Abstract][Full Text] [Related]
47. Intracellular glutathione levels in human colon cancer cells naturally resistant to cross-linking agents.
Ozawa S; Iwata K; Kubodera A; Inaba M
J Pharmacobiodyn; 1989 Jul; 12(7):378-83. PubMed ID: 2593079
[TBL] [Abstract][Full Text] [Related]
48. Modes of action of alpha-hederin and thymoquinone, active constituents of Nigella sativa, against HEp-2 cancer cells.
Rooney S; Ryan MF
Anticancer Res; 2005; 25(6B):4255-9. PubMed ID: 16309225
[TBL] [Abstract][Full Text] [Related]
49. Necrosis and apoptosis associated with distinct Ca2+ response patterns in target cells attacked by human natural killer cells.
Oshimi Y; Oshimi K; Miyazaki S
J Physiol; 1996 Sep; 495 ( Pt 2)(Pt 2):319-29. PubMed ID: 8887746
[TBL] [Abstract][Full Text] [Related]
50. Effect of phenols on natural killer (NK) cell-mediated death in the K562 human leukemic cell line.
Dedoussis GV; Kaliora AC; Andrikopoulos NK
Cell Biol Int; 2005 Nov; 29(11):884-9. PubMed ID: 16198604
[TBL] [Abstract][Full Text] [Related]
51. [Effect of reduced glutathione as anti-leukemic immune adjuvant].
Pan JX; Lin L; Guo JX; Zhu YG; Cai JF; Guo XZ; Chen ZZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):359-62. PubMed ID: 16638215
[TBL] [Abstract][Full Text] [Related]
52. Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines.
Newkirk K; Heffern J; Sloman-Moll E; Sessions RB; Rasmussen AA; Andrews PA; Cullen KJ
Cancer Chemother Pharmacol; 1997; 40(1):75-80. PubMed ID: 9137534
[TBL] [Abstract][Full Text] [Related]
53. Dexamethasone-resistant human Pre-B leukemia 697 cell line evolving elevation of intracellular glutathione level: an additional resistance mechanism.
Inoue H; Takemura H; Kawai Y; Yoshida A; Ueda T; Miyashita T
Jpn J Cancer Res; 2002 May; 93(5):582-90. PubMed ID: 12036455
[TBL] [Abstract][Full Text] [Related]
54. Depletion of glutathione by buthionine sulfoxine is cytotoxic for human neuroblastoma cell lines via apoptosis.
Anderson CP; Tsai JM; Meek WE; Liu RM; Tang Y; Forman HJ; Reynolds CP
Exp Cell Res; 1999 Jan; 246(1):183-92. PubMed ID: 9882527
[TBL] [Abstract][Full Text] [Related]
55. Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2.
Kim HS; Lee JH; Kim IK
Prostaglandins; 1996 Jun; 51(6):413-25. PubMed ID: 8873236
[TBL] [Abstract][Full Text] [Related]
56. Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O6-benzylguanine.
Fishel ML; Gamcsik MP; Delaney SM; Zuhowski EG; Maher VM; Karrison T; Moschel RC; Egorin MJ; Dolan ME
Cancer Chemother Pharmacol; 2005 Apr; 55(4):333-342. PubMed ID: 15723259
[TBL] [Abstract][Full Text] [Related]
57. Effect of glutathione depletion on cisplatin resistance in cancer cells transfected with the gamma-glutamylcysteine synthetase gene.
Kurokawa H; Nishio K; Ishida T; Arioka H; Fukuoka K; Nomoto T; Fukumoto H; Yokote H; Saijo N
Jpn J Cancer Res; 1997 Feb; 88(2):108-10. PubMed ID: 9119737
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological inhibitors of extracellular signal-regulated protein kinases attenuate the apoptotic action of cisplatin in human myeloid leukemia cells via glutathione-independent reduction in intracellular drug accumulation.
Amrán D; Sancho P; Fernández C; Esteban D; Ramos AM; de Blas E; Gómez M; Palacios MA; Aller P
Biochim Biophys Acta; 2005 Apr; 1743(3):269-79. PubMed ID: 15843040
[TBL] [Abstract][Full Text] [Related]
59. Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum.
Ikeda K; Miura K; Himeno S; Imura N; Naganuma A
Mol Cell Biochem; 2001 Mar; 219(1-2):51-6. PubMed ID: 11354253
[TBL] [Abstract][Full Text] [Related]
60. Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis.
Umansky V; Rocha M; Breitkreutz R; Hehner S; Bucur M; Erbe N; Dröge W; Ushmorov A
J Cell Biochem; 2000 Jun; 78(4):578-87. PubMed ID: 10861855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
